Completed PHASE2 INTERVENTIONAL 1-arm NCT04332380

Convalescent Plasma for Patients With COVID-19: A Pilot Study (CP-COVID-19)

Sponsor: CES University

Conditions Coronavirus Coronavirus Infection

Interventions Plasma

Updated 5 times since 2020 Last updated: Aug 12, 2020 Started: May 1, 2020 Primary completion: Jul 28, 2020 Completion: Jul 28, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04332380, this PHASE2 trial focuses on Coronavirus and Coronavirus Infection and remains completed. Sponsored by CES University, it has been updated 5 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Sep 2020 — Jan 2021 [monthly]

Completed PHASE2

Status: Not Yet Recruiting → Completed
May 2020 — Sep 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CES University
Fundación Universitaria de Ciencias de la Salud
Instituto Distrital de Ciencia Biotecnologia e Innovacion en salud
Universidad del Rosario

Data source: Universidad del Rosario

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bogota, Colombia